FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
January 20, 2006
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: January 20, 2006
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
SMITH & NEPHEW ANNOUNCEMENT DATES FOR 2006 AND DETAILS OF THE BRIEFING AT THE
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
20 January 2006
Smith & Nephew plc (NYSE:SNN; LSE:SN) will announce its preliminary results for
2005 at 11am GMT/6.00am EST on 9 February 2006. A presentation for analysts will
be held at 1.00pm GMT/8.00am EST which can be seen live via webcast on the Smith
& Nephew website at www.smith-nephew.com and available on the site archive
shortly afterwards.
The company will announce its quarterly results through the year as follows:
Quarter 1 27 April 2006
Interims/Quarter 2 27 July 2006
Quarter 3 2 November 2006
The company will host a meeting for analysts and investors at the American
Academy of Orthopaedic Surgeons (AAOS), the largest orthopaedic congress in the
world, at 8.00am (EST) on Wednesday 22 March 2006 in Chicago.
The meeting will be hosted by Sir Christopher O'Donnell, Chief Executive, with
presentations from Dave Illingworth, President of Smith & Nephew's orthopaedics
business, and Jim Taylor, President of the endoscopy business. The presentations
will focus on Smith & Nephew products being exhibited by the orthopaedic and
endoscopy businesses at the surgeon meeting. These will also be broadcast live
by webcast on the Smith & Nephew website and will be available on the site
archive shortly afterwards.
About Us
Smith & Nephew (LSE: SN, NYSE:SNN) is one of the world's leading medical devices
companies, specialising in Orthopaedics, Endoscopy and Advanced Wound
Management. Smith & Nephew ranks as the global leader in arthroscopy and
advanced wound management and is the fastest growing full-line orthopaedics
company in the world.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself on the strength of its relationships with its surgeon and
healthcare professional customers, with whom its name is synonymous with the
highest standards of performance, innovation and trust. The company has over
8,500 employees and operates in 33 countries around the world, generating sales
of over GBP1.25 billion.
Enquiries:
Smith & Nephew UK
Julie Allen Tel: +44 (0)20 7401 7646
Investor Relations Coordinator
Financial Dynamics UK
David Yates/Ben Atwell Tel: +44 (0)20 7831 3113
Financial Dynamics US
Jonathan Birt Tel: +1 212 850 5634